Clemons M, Ong M, Stober C, Ernst S, et al. A randomised trial of 4- versus 12-weekly administration of bone-targeted agents
in patients with bone metastases from breast or castration-resistant prostate
cancer. Eur J Cancer 2021;142:132-140.
PMID: 33023785